6-Iodo-1H-indazole: Key Intermediate for Advanced Pharmaceutical Synthesis
Explore the synthesis, properties, and critical applications of 6-Iodo-1H-indazole, an essential building block.
Get a Quote & SampleProduct Core Value
6-Iodo-1H-indazole
6-Iodo-1H-indazole is a vital pharmaceutical intermediate, primarily recognized for its role in the synthesis of Axitinib. This compound is characterized by its specific chemical structure and properties, making it indispensable for creating advanced pharmaceutical agents.
- Discover the 6-iodo-1H-indazole synthesis pathways that offer improved yield and reduced environmental impact.
- Understand the critical role of this Axitinib intermediate with CAS number 261953-36-0 in modern drug development.
- Learn about the high purity 6-iodo-1H-indazole, a testament to meticulous manufacturing processes.
- Explore the detailed chemical properties of 6-iodo-1h-indazole, including its density and boiling point, crucial for process optimization.
Key Advantages
Enhanced Purity
Achieve superior results with our high purity 6-iodo-1H-indazole, ensuring reliability in complex synthetic procedures.
Streamlined Synthesis
Benefit from optimized 6-iodo-1H-indazole synthesis methods that lead to higher yields and a more efficient production cycle.
Critical for Axitinib
As a vital Axitinib intermediate, this compound supports the development of targeted cancer therapies, making its buy availability crucial.
Key Applications
Pharmaceutical Intermediate
This compound serves as a foundational element for synthesizing complex Active Pharmaceutical Ingredients (APIs), particularly targeting conditions like cancer.
Axitinib Production
Its primary use is as a key intermediate in the manufacture of Axitinib, a tyrosine kinase inhibitor crucial for cancer treatment.
Organic Synthesis Building Block
Researchers and manufacturers utilize its unique structure for various advanced organic synthesis projects.
Research and Development
Essential for R&D in discovering and developing new therapeutic agents, contributing to the pharmaceutical innovation landscape.